MARKET WIRE NEWS
  1. Home
  2. Stock
  3. FATE
  4. News
  5. Fate Therapeutics Reports Q4 Results
FATE
Quote
Short
News
Articles
Message Board

Fate Therapeutics reports Q4 results

Source: SeekingAlpha

2026-02-26 10:16:24 ET

More on Fate Therapeutics

Read the full article on Seeking Alpha

For further details see:

Fate Therapeutics reports Q4 results
Fate Therapeutics Inc.

NASDAQ: FATE

FATE Trading

7.56% G/L:

$1.98 Last:

2,318,446 Volume:

$2.02 Open:

mwn-link-x Ad 300

FATE Latest News

May 13, 2026 08:30:00 am
Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
May 11, 2026 08:30:00 am
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting
May 05, 2026 08:30:00 am
Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819
May 04, 2026 09:00:00 am
Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases

FATE Stock Data

$128,041,041
108,996,378
1.54%
45
N/A
Biotechnology & Life Sciences
Healthcare
https://www.fatetherapeutics.com
US
San Diego

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App